Lv1
80 积分 2022-11-06 加入
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial
12小时前
待确认
HSFSurv: A hybrid supervision framework at individual and feature levels for multimodal cancer survival analysis
7个月前
已完结
Cohort-Individual Cooperative Learning for Multimodal Cancer Survival Analysis
7个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
7个月前
已完结
Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study
8个月前
已完结
皖公网安备34019202002308
